Prestige Wealth Management Group’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-136
Closed -$1.9K – 1072
2023
Q3
$1.9K Buy
+136
New +$1.74K ﹤0.01% 751
2019
Q1
– Sell
-51
Closed -$1K – 1009
2018
Q4
$1K Buy
+51
New +$1.03K ﹤0.01% 1109

Other funds holding SBRA

Prestige Wealth Management Group's SBRA Position: Q4 2023 in Review

Prestige Wealth Management Group sold out of Sabra Healthcare REIT (SBRA) in Q4 2023, closing a stake of 136 shares — an estimated $1.9K sold.

Prestige Wealth Management Group first reported a position in SBRA in Q4 2018 and held it in 2 quarters. The position peaked at $1.9K in Q3 2023. 359 funds tracked by Wall St. Rank hold SBRA as of Q4 2023.

  • Prestige Wealth Management Group reported no remaining Sabra Healthcare REIT position as of Q4 2023 after selling out during the quarter.
  • Prestige Wealth Management Group sold 136 Sabra Healthcare REIT shares in Q4 2023, an estimated $1.9K.
  • Prestige Wealth Management Group first reported a position in Sabra Healthcare REIT in Q4 2018 and held it in 2 quarters.
  • Prestige Wealth Management Group's Sabra Healthcare REIT position peaked at $1.9K in Q3 2023.
  • 359 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2023.

Based on Prestige Wealth Management Group's 13F filing for Q4 2023, filed 8 Feb 2024.